PlainRecalls
FDA Drug Moderate Class II Ongoing

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

Reported: October 9, 2024 Initiated: September 23, 2024 #D-0007-2025

Product Description

Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61

Reason for Recall

CGMP deviations

Details

Units Affected
99 doses
Distribution
FL, MA, NJ, NY, PA, and VA
Location
Millburn, NJ

Frequently Asked Questions

What product was recalled?
Pluvicto, 1000 MBq/mL (27 mCi/mL), lutetium, LU 177, vipivotide tetraxetan injection, Single-dose vial, Sterile, Manufacturer Advanced Accelerator Applications, 57 E. Willow Street, NJ 07041, Millburn USA. NDC 69488-0010-61. Recalled by Advanced Accelerator Applications USA, Inc.. Units affected: 99 doses.
Why was this product recalled?
CGMP deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on October 9, 2024. Severity: Moderate. Recall number: D-0007-2025.